Placing the patient at the heart of discovery science

Mihaela Aldea; Elsa Bernard; Charles Swanton; Fabrice Andre

doi:10.1016/j.ejca.2023.113306

Placing the patient at the heart of discovery science

Mihaela Aldea, Elsa Bernard, Charles Swanton, Fabrice Andre

Résultats de recherche: Contribution à un journal › Editorial

langue originale	Anglais
Numéro d'article	113306
journal	European Journal of Cancer
Volume	193
Les DOIs	https://doi.org/10.1016/j.ejca.2023.113306
état	Publié - 1 nov. 2023

Accès au document

10.1016/j.ejca.2023.113306

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{0cae2a0217e54339b534a85a05d25156,

title = "Placing the patient at the heart of discovery science",

author = "Mihaela Aldea and Elsa Bernard and Charles Swanton and Fabrice Andre",

note = "Funding Information: C.S. is a Royal Society Napier Research Professor (RSRP\R\210001). His work is supported by the Francis Crick Institute that receives its core funding from Cancer Research UK (CC2041), the UK Medical Research Council (CC2041), and the Wellcome Trust (CC2041). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. C.S. is funded by Cancer Research UK (TRACERx (C11496/A17786), PEACE (C416/A21999) and CRUK Cancer Immunotherapy Catalyst Network); Cancer Research UK Lung Cancer Centre of Excellence (C11496/A30025); the Rosetrees Trust, Butterfield and Stoneygate Trusts; NovoNordisk Foundation (ID16584); Royal Society Professorship Enhancement Award (RP/EA/180007); National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; the Cancer Research UK-University College London Centre; Experimental Cancer Medicine Centre; the Breast Cancer Research Foundation (US) (BCRF-22-157); Cancer Research UK Early Detection an Diagnosis Primer Award (Grant EDDPMA-Nov21/100034); and The Mark Foundation for Cancer Research Aspire Award (Grant 21-029-ASP). This work was supported by a Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant (Grant Number: SU2C-AACR-DT23-17 to S.M. Dubinett and A.E. Spira). Stand Up To Cancer is a division of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the Scientific Partner of SU2C. CS is in receipt of an ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union{\textquoteright}s Horizon 2020 research and innovation programme (grant agreement no. 835297). ",

year = "2023",

month = nov,

day = "1",

doi = "10.1016/j.ejca.2023.113306",

language = "English",

volume = "193",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

TY - JOUR

T1 - Placing the patient at the heart of discovery science

AU - Aldea, Mihaela

AU - Bernard, Elsa

AU - Swanton, Charles

AU - Andre, Fabrice

N1 - Funding Information: C.S. is a Royal Society Napier Research Professor (RSRP\R\210001). His work is supported by the Francis Crick Institute that receives its core funding from Cancer Research UK (CC2041), the UK Medical Research Council (CC2041), and the Wellcome Trust (CC2041). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. C.S. is funded by Cancer Research UK (TRACERx (C11496/A17786), PEACE (C416/A21999) and CRUK Cancer Immunotherapy Catalyst Network); Cancer Research UK Lung Cancer Centre of Excellence (C11496/A30025); the Rosetrees Trust, Butterfield and Stoneygate Trusts; NovoNordisk Foundation (ID16584); Royal Society Professorship Enhancement Award (RP/EA/180007); National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; the Cancer Research UK-University College London Centre; Experimental Cancer Medicine Centre; the Breast Cancer Research Foundation (US) (BCRF-22-157); Cancer Research UK Early Detection an Diagnosis Primer Award (Grant EDDPMA-Nov21/100034); and The Mark Foundation for Cancer Research Aspire Award (Grant 21-029-ASP). This work was supported by a Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant (Grant Number: SU2C-AACR-DT23-17 to S.M. Dubinett and A.E. Spira). Stand Up To Cancer is a division of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the Scientific Partner of SU2C. CS is in receipt of an ERC Advanced Grant (PROTEUS) from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 835297).

PY - 2023/11/1

Y1 - 2023/11/1

UR - http://www.scopus.com/inward/record.url?scp=85171665644&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2023.113306

DO - 10.1016/j.ejca.2023.113306

M3 - Editorial

AN - SCOPUS:85171665644

SN - 0959-8049

VL - 193

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 113306

ER -